GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Piotroski F-Score

Autobio Diagnostics Co (SHSE:603658) Piotroski F-Score : 6 (As of Dec. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Autobio Diagnostics Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Autobio Diagnostics Co's Piotroski F-Score or its related term are showing as below:

SHSE:603658' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 8
Current: 6

During the past 13 years, the highest Piotroski F-Score of Autobio Diagnostics Co was 8. The lowest was 3. And the median was 5.


Autobio Diagnostics Co Piotroski F-Score Historical Data

The historical data trend for Autobio Diagnostics Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co Piotroski F-Score Chart

Autobio Diagnostics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 5.00 4.00 8.00 5.00

Autobio Diagnostics Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 5.00 6.00 6.00

Competitive Comparison of Autobio Diagnostics Co's Piotroski F-Score

For the Medical Devices subindustry, Autobio Diagnostics Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Autobio Diagnostics Co's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was 316.519 + 324.212 + 295.301 + 336.661 = ¥1,273 Mil.
Cash Flow from Operations was 518.743 + 328.402 + 167.089 + 453.475 = ¥1,468 Mil.
Revenue was 1201.158 + 1089.195 + 1117.909 + 1172.931 = ¥4,581 Mil.
Gross Profit was 797.003 + 702.742 + 739.968 + 783.5 = ¥3,023 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(11072.22 + 11554.058 + 11605.923 + 11037.703 + 11389.47) / 5 = ¥11331.8748 Mil.
Total Assets at the begining of this year (Sep23) was ¥11,072 Mil.
Long-Term Debt & Capital Lease Obligation was ¥23 Mil.
Total Current Assets was ¥6,135 Mil.
Total Current Liabilities was ¥2,388 Mil.
Net Income was 268.551 + 242.07 + 303.803 + 355.047 = ¥1,169 Mil.

Revenue was 1160.146 + 1036.467 + 1071.475 + 1134.556 = ¥4,403 Mil.
Gross Profit was 692.354 + 632.824 + 708.78 + 752.803 = ¥2,787 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(10229.578 + 10472.319 + 10512.373 + 10580.204 + 11072.22) / 5 = ¥10573.3388 Mil.
Total Assets at the begining of last year (Sep22) was ¥10,230 Mil.
Long-Term Debt & Capital Lease Obligation was ¥80 Mil.
Total Current Assets was ¥6,381 Mil.
Total Current Liabilities was ¥2,272 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Autobio Diagnostics Co's current Net Income (TTM) was 1,273. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Autobio Diagnostics Co's current Cash Flow from Operations (TTM) was 1,468. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=1272.693/11072.22
=0.1149447

ROA (Last Year)=Net Income/Total Assets (Sep22)
=1169.471/10229.578
=0.11432251

Autobio Diagnostics Co's return on assets of this year was 0.1149447. Autobio Diagnostics Co's return on assets of last year was 0.11432251. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Autobio Diagnostics Co's current Net Income (TTM) was 1,273. Autobio Diagnostics Co's current Cash Flow from Operations (TTM) was 1,468. ==> 1,468 > 1,273 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=23.411/11331.8748
=0.00206594

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=79.521/10573.3388
=0.0075209

Autobio Diagnostics Co's gearing of this year was 0.00206594. Autobio Diagnostics Co's gearing of last year was 0.0075209. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=6134.702/2387.938
=2.56903739

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=6380.528/2271.767
=2.80861902

Autobio Diagnostics Co's current ratio of this year was 2.56903739. Autobio Diagnostics Co's current ratio of last year was 2.80861902. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Autobio Diagnostics Co's number of shares in issue this year was 601.777. Autobio Diagnostics Co's number of shares in issue last year was 582.285. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=3023.213/4581.193
=0.65991828

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=2786.761/4402.644
=0.63297441

Autobio Diagnostics Co's gross margin of this year was 0.65991828. Autobio Diagnostics Co's gross margin of last year was 0.63297441. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=4581.193/11072.22
=0.4137556

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=4402.644/10229.578
=0.43038374

Autobio Diagnostics Co's asset turnover of this year was 0.4137556. Autobio Diagnostics Co's asset turnover of last year was 0.43038374. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+0+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Autobio Diagnostics Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Autobio Diagnostics Co  (SHSE:603658) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Autobio Diagnostics Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Autobio Diagnostics Co Business Description

Traded in Other Exchanges
N/A
Address
No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production and sales of in vitro diagnostic reagents and instruments.
Executives
Miao Yong Jun Director

Autobio Diagnostics Co Headlines

No Headlines